TD Cowen Upgrades Pacira Pharmaceuticals (PCRX) to Outperform, 'Anticipate Sentiment Reversal In 2H23'

Go back to TD Cowen Upgrades Pacira Pharmaceuticals (PCRX) to Outperform, 'Anticipate Sentiment Reversal In 2H23'

Form S-8 Pacira BioSciences, Inc.

August 2, 2023 4:35 PM EDT

As filed with the Securities and Exchange Commission on August 2, 2023                                         Registration No.... More

Form 144 Pacira BioSciences, Inc. Filed by: WINSTON ROY

August 2, 2023 3:55 PM EDT

ATTACHMENTS / EXHIBITS

primary_doc.xml

... More

Form 10-Q Pacira BioSciences, Inc. For: Jun 30

August 2, 2023 2:48 PM EDT

... More

Form 8-K Pacira BioSciences, Inc. For: Aug 02

August 2, 2023 8:03 AM EDT

... More